New drug TB006 aims to ease Parkinson's symptoms in Early-Stage patients
Symptom relief
Ongoing
This study tests an experimental drug called TB006 in 62 people with early-stage Parkinson's disease. The goal is to see if it safely improves motor function and reduces symptoms. Participants receive either TB006 or a placebo, and researchers track changes in movement and overal…
Phase: PHASE2 • Sponsor: TrueBinding, Inc. • Aim: Symptom relief
Last updated May 08, 2026 12:00 UTC